-+ 0.00%
-+ 0.00%
-+ 0.00%

ORIC PHARMACEUTICALS, - CANCER RESEARCH UK TO FULLY FUND AND EXECUTE EARLY CLINICAL DEVELOPMENT OF ORIC-259

Reuters·10/05/2026 20:01:00

Please log in to view news